NCT07001267

Brief Summary

This study is being done to compare outcomes after surgery for individuals who receive anesthesia through by inhaling medication and individuals who receive anesthesia intravenously by needle when experiencing treatment for their stroke. Currently very little is known about the outcomes for patients when comparing these two techniques of providing anesthesia during surgery. This study will provide information regarding outcomes that will help health care providers decide which technique will be better for patients

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Jun 2025Dec 2027

First Submitted

Initial submission to the registry

May 23, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 3, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

June 4, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

May 23, 2025

Last Update Submit

March 10, 2026

Conditions

Keywords

Inhalation anesthesiaIntravenous anesthesia

Outcome Measures

Primary Outcomes (1)

  • Functional Independence at 90 days

    The primary end point is functional independence at 90 days evaluated with the modified Rankin Scale (mRS). We plan to compare the functional recovery in 90 days in patients undergoing inhalational versus intravenous general anesthesia during mechanical thrombectomy using the modified Rankin score (mRS) in patients who suffered an acute ischemic stroke. (The mRS assesses a patient's functional independence or dependence after a stroke. Scores range from 0 (no symptoms) to 6 (death), with 0-2 indicating functional independence and 3-5 indicating dependence. A separate category of 6 is often added for patients who have died)

    From enrollment to 90 days after treatment

Secondary Outcomes (2)

  • Comparison of National Institutes of Health Stroke Scale (NIHSS) score

    From enrollment to 90 days after treatment

  • Thrombolysis in Cerebral Infarction (TICI) score

    From enrollment to 90 days after treatment

Study Arms (2)

inhalational sevoflurane

ACTIVE COMPARATOR

When treated for acute ischemic stroke, patient will receive inhalation sevoflurane as anesthesia

Procedure: Anesthesia drugs during the surgery

intravenous propofol infusion

ACTIVE COMPARATOR

When treated for acute ischemic stroke, patient will receive intravenous propofol infusion as anesthesia

Procedure: Anesthesia drugs during the surgery

Interventions

During treatment for acute ischemic stroke, patients will be given either inhalation or intravenous anesthesia.

inhalational sevofluraneintravenous propofol infusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years Acute ischemic stroke requiring endovascular treatment.

You may not qualify if:

  • \<18 years
  • Pregnant patients
  • Patients with malignant hyperthermia
  • Allergies or any contraindications to either inhalational or intravenous agents
  • Patients already on intravenous anesthetic infusions
  • Prisoners
  • Students and employees

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

RECRUITING

Study Officials

  • Arun George, MD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arun George, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2025

First Posted

June 3, 2025

Study Start

June 4, 2025

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations